Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells
Advanced Healthcare Materials · 2025-05 · 14 (12)
DOI: 10.1002/adhm.202403490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 28.11.2024. Verfasst von Qiming Pang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, China. Hauptthemen laut MEDLINE: Osteoarthritis, Microspheres, Mesenchymal Stem Cells, Cell Differentiation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing, China, Postdoctoral Special Funding Project of Chongqing Human Resources and Social Security Bureau, National Natural Science Foundation of China - Joint Fund Project.
Abstract (Originalsprache)
Osteoarthritis (OA) represents a common degenerative joint disorder marked by progressive cartilage degradation, necessitating innovative therapeutic approaches beyond symptom management. Here, this study introduces a novel strategy leveraging the regenerative capabilities of mesenchymal stem cells (MSCs) by utilizing a bioactive extracellular matrix (ECM) derived from IFN‐ γ ‐stimulated MSCs, encapsulated within aldehyde‐ and methacrylic anhydride‐modified hyaluronic acid hydrogel microspheres (AH). This engineered scaffold effectively mimics the native cartilage microenvironment, promoting targeted adhesion and retention at damaged sites via spontaneous Schiff base reactions. Notably, the IFN‐ γ ‐ECM@AH microspheres facilitate the localized release of key chemokines, such as CXCL12, enhancing endogenous stem cell recruitment, and bioactive factors (e.g., TGF‐ β I and TGF‐ β 3) to drive chondrogenic differentiation. Additionally, the scaffold possesses binding sites for cellular integrins, further augmenting the regenerative potential of stem cells. Collectively, the approach presents a dual‐action mechanism that supports efficient cartilage repair and regeneration, positioning this engineered microenvironment as a promising therapeutic avenue for OA and potentially other degenerative conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, China.
- Chongqing Municipal Health Commission Key Laboratory of Musculoskeletal Regeneration and Translational Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400042, China.
- Orthopaedic Research Laboratory of Chongqing Medical University, Chongqing Medical University, Chongqing, 400042, China.
ORCID-Profile: Wei Huang
Förderung
- Natural Science Foundation of Chongqing, China
- Postdoctoral Special Funding Project of Chongqing Human Resources and Social Security Bureau
- National Natural Science Foundation of China - Joint Fund Project
- Postdoctoral Cultivating Project of the First Affiliated Hospital of Chongqing Medical University
Zitieren
APA
Pang, Q., Chen, Z., Zhan, J., Liu, J., Liu, J., Zhao, W., Huang, W., & Dong, L. (2025). Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells. Advanced Healthcare Materials, 14(12). https://doi.org/10.1002/adhm.202403490
Vancouver
Pang Q, Chen Z, Zhan J, Liu J, Liu J, Zhao W, et al. Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells. Advanced Healthcare Materials. 2025;14(12). doi:10.1002/adhm.202403490
BibTeX
@article{Pang2025,
author = {Pang, Qiming and Chen, Zhuolin and Zhan, Jingdi and Liu, Jiacheng and Liu, Junyan and Zhao, Weikang and Huang, Wei and Dong, Lili},
title = {Localized Hydrogel Microspheres for Osteoarthritis Treatment: Recruitment and Differentiation of Stem Cells},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {12},
doi = {10.1002/adhm.202403490}
}
EUVIMED